Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
Open Access
- 22 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Imaging
- Vol. 20 (1), 1-7
- https://doi.org/10.1186/s40644-020-00309-y
Abstract
Previous work has demonstrated that metastases are not uniformly distributed across the brain. This study aims to determine there are low-risk brain metastasis (BM) areas that may be avoided during whole-brain radiotherapy (WBRT) to reduce neurocognitive toxicity. Clinical and magnetic resonance imaging (MRI) data of 991 metastases in 192 patients with advanced cancer were analyzed retrospectively. Eleven anatomically defined regions of interest (ROIs) were contoured, and the locations of the BMs were recorded. Using the same definition, ROIs were contoured in 20 healthy volunteers.The proportions of patients with BMs in different ROIs, proportion of BMs, and proportion of different ROI volumes relative to the total volume were calculated. The proportion of observed BMs was lower than expected in the brainstem, insula, diencephalon and internal structures, corpus callosum, and pituitary gland. The proportion of BMs was significantly higher than expected in the parietal lobe, occipital lobe, and cerebellum. For those patients with single BM, there was very low rate of low-risk ROIs involvement (0%), with 2–4 BMs, 6–13% of the patients had low-risk ROIs involvement, with ≥5 BMs, significant (> 30%) of the patients had low-risk ROIs involvement. The brainstem, insula, diencephalon and internal structures, corpus callosum, and pituitary gland demonstrate low risk for metastatic involvement. Involvement of low risk areas occurs in patients with more than 1 BM.Keywords
Funding Information
- Mianyang Science and Technology Bureau (15-S01-3)
This publication has 24 references indexed in Scilit:
- Implications for preserving neural stem cells in whole brain radiotherapy and prophylactic cranial irradiation: a review of 2270 metastases in 488 patientsJournal of Radiation Research, 2012
- Normal Brain Anatomy on Magnetic Resonance ImagingMagnetic Resonance Imaging Clinics of North America, 2011
- Distribution of brain metastases: implications for non-uniform dose prescriptionsThe British Journal of Radiology, 2011
- Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: Safety profile for RTOG 0933Radiotherapy and Oncology, 2010
- The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineJournal of Neuro-Oncology, 2009
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialThe Lancet Oncology, 2009
- Distribution of Brain Metastases in Relation to the Hippocampus: Implications for Neurocognitive Functional PreservationInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 2004
- Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using rtog study 7916International Journal of Radiation Oncology*Biology*Physics, 1989
- Distribution of Brain MetastasesArchives of Neurology, 1988